Folate in smokers

Clinica Chimica Acta

Volumn 412, Issue 7-8, 2011, Pages 521-526

  Okumura, Kenji ^a   Tsukamoto, Hideto ^a  

^a Toki Municipal General Hospital   (Japan)

Author keywords

Folate; Folic acid; Methionine synthase; Remethylation; Transsulfuration

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; PYRIDOXINE; S ADENOSYLMETHIONINE; TAR; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CIGARETTE SMOKING; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EATING HABIT; ENDOTHELIAL DYSFUNCTION; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; FOOD INTAKE; FRUIT; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; LIFESTYLE; NEURAL TUBE DEFECT; PASSIVE SMOKING; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; TREATMENT OUTCOME; VEGETABLE;

FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; RISK FACTORS; SMOKING;

NICOTIANA TABACUM;

EID: 79551481182     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.01.003     Document Type: Review

References (91)

1. World Health Organization WHO Report on the Global Tobacco Epidemic 2009: implementing smoke-free environments 2009, WHO, Geneva. http://www.who.int/tobacco/mpower/2009/en/index.html.
2. Smith A.D., Kim Y.I., Refsum H. Is folic acid good for everyone?. Am J Clin Nutr 2008, 87:517-533.
3. Herbert V., Tisman G., Go Le-Teng, Brenner L. The dU suppression test using 125 I-UdR to define biochemical megaloblastosis. Br J Haematol 1973, 24:713-723.
4. Montgomery R.D., Beale D.J., Sammons H.G., Schneider R. Postinfective malabsorption: a sprue syndrome. Br Med J 1973, 2:265-268.
5. Halsted C.H., Villanueva J.A., Devlin A.M., Chandler C.J. Metabolic interactions of alcohol and folate. J Nutr 2002, 132:2367S-2372S.
6. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969, 56:111-128.
7. Kanwar Y.S., Manaligod J.R., Wong P.W. Morphologic studies in a patient with homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency. Pediatr Res 1976, 10:598-609.
8. Christensen B., Landaas S., Stensvold I., et al. Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction. Atherosclerosis 1999, 147:317-326.
9. Morrison H.I., Schaubel D., Desmeules M., Wigle D.T. Serum folate and risk of fatal coronary heart disease. JAMA 1996, 275:1893-1896.
10. Mudd S.H., Skovby F., Levy H.L., et al. The natural history of homocystinuria due to cystathionine ß-synthase deficiency. Am J Hum Genet 1985, 37:1-31.
11. Stampfer M.J., Willett W.C. Homocysteine and marginal vitamin deficiency: the importance of adequate vitamin intake. JAMA 1993, 270:2726-2727.
12. Engbersen A.M.T., Franken D.G., Boers G.H.J., Stevens E.M.B., Trijbels F.J.M., Blom H.J. Thermolabile 5,10-methylene tetrahydrofolate reductase as cause of mild hyperhomocystinemia. Am J Hum Genet 1995, 56:142-150.
13. Smolders R.G., de Meer K., Kenemans P., Teerlink T., Jakobs C., van der Mooren M.J. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2004, 117:55-59.
14. Olthof M.R., Bots M.L., Katan M.B., Verhoef P. Acute effect of folic acid, betaine, and serine supplements on flow-mediated dilation after methionine loading: a randomized trial. PLoS Clin Trials 2006, 1:e4.
15. Alfthan G., Pekkanen J., Jauhiainen M., et al. Relation of serum homocysteine and lipoprotein(a) concentrations to athelosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994, 106:9-19.
16. Malinow M.R., Nieto F.J., Szklo M., et al. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the atherosclerosis risk in communities study. Circulation 1993, 87:1107-1113.
17. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991, 324:1149-1155.
18. Genest J.J., McNamara J.R., Salem D.N., et al. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990, 16:1114-1119.
19. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarctions in US physicians. JAMA 1992, 268:877-881.
20. Boushey C.J., Beresford S.A., Omenn G.S., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
21. Elrod J.W., Calvert J.W., Morrison J., et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007, 104:15560-15565.
22. Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997, 237:527-531.
23. Zhao W., Zhang J., Lu Y., Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001, 20:6008-6016.
24. Li L., Bhatia M., Zhu Y.Z., et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005, 19:1196-1198.
25. Nishio K., Goto Y., Kondo T., et al. Serum folate and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism adjusted for folate intake. J Epidemiol 2008, 18:125-131.
26. Imamura A., Murakami R., Takahashi R., et al. Low folate levels may be an atherogenic factor regardless of homocysteine levels in young healthy nonsmokers. Metabolism 2010, 59:728-733.
27. Schwartz S.M., Siscovick D.S., Malinow M.R., et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997, 96:412-417.
28. Verhoef P., Stampfer M.J., Buring J.E., et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996, 143:845-859.
29. Bunout D., Petermann M., Hirsch S., et al. Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition 2000, 16:434-438.
30. Dalery K., Lussier-Cacan S., Selhub J., Davignon J., Latour Y., Genest J. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol 1995, 75:1107-1111.
31. Robinson K., Mayer E.L., Miller D.P., et al. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 1995, 92:2825-2830.
32. Verhoef P., Meleady R., Daly L.E., et al. Homocysteine, vitamin status and risk of vascular disease: effects of gender and menopausal status. Eur Heart J 1999, 20:1234-1244.
33. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 1997, 277:1775-1781.
34. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288:2015-2022. Homocysteine Studies Collaboration.
35. Verhoef P., Katan M.B. A healthy lifestyle lowers homocysteine, but should we care?. Am J Clin Nutr 2004, 79:713-714.
36. Bellamy M.F., McDowell I.F., Ramsey M.W., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998, 98:1848-1852.
37. Chao C.L., Chien K.L., Lee Y.T. Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia. Am J Cardiol 1999, 84:1359-1361. A8.
38. Yang Q., Botto L.D., Erickson J.D., et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006, 113:1335-1343.
39. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998, 316:894-898. Homocysteine Lowering Trialists' Collaboration.
40. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005, 82:806-812. Homocysteine Lowering Trialists' Collaboration.
41. Toole J.F., Malinow M.R., Chambless L.E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291:565-575.
42. Bønaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578-1588. NORVIT Trial Investigators.
43. Lonn E., Yusuf S., Arnold M.J., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567-1577.
44. Ebbing M., Bleie Ø., Ueland P.M., et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008, 300:795-804.
45. Jamison R.L., Hartigan P., Kaufman J.S., et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007, 298:1163-1170. Veterans Affairs Site Investigators.
46. Albert C.M., Cook N.R., Gaziano J.M., et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299:2027-2036.
47. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010, 303:2486-2494. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group.
48. Verhaar M.C., Stroes E., Rabelink T.J. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 2002, 22:6-13.
49. Chang P.Y., Lu S.C., Lee C.M., et al. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 2008, 102:933-941.
50. Villa P., Perri C., Suriano R., et al. l-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab 2005, 90:4622-4629.
51. Chauveau P., Chadefaux B., Coude M., et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993, 43:S72-S77.
52. Giltay E.J., Hoogeveen E.K., Elbers J.M., Gooren L.J., Asscheman H., Stehouwer C.D. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, nonobese subjects. Atherosclerosis 1998, 139:197-198. [letter].
53. Eberhardt R.T., Forgione M.A., Cap A., et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 2000, 106:483-491.
54. Berstad P., Konstantinova S.V., Refsum H., et al. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. Am J Clin Nutr 2007, 85:1598-1605.
55. Liao D., Tan H., Hui R., Li Z., et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res 2006, 99:598-606.
56. Milani R.V., Lavie C.J. Homocysteine: the Rubik's cube of cardiovascular risk factors. Mayo Clin Proc 2008, 83:1200-1202.
57. Piyathilake C.J., Macaluso M., Hine R.J., Vinter D.W., Richards E.W., Krumdieck C.L. Cigarette smoking, intracellular vitamin deficiency, and occurrence of micronuclei in epithelial cells of the buccal mucosa. Cancer Epidemiol Biomark Prev 1995, 4:751-758.
58. Walmsley C.M., Bates C.J., Prentice A., Cole T.J. Relationship between cigarette smoking and nutrient intakes and blood status indices of older people living in the UK: further analysis of data from the National Diet and Nutrition Survey of people aged 65years and over, 1994/95. Public Health Nutr 1999, 2:199-208.
59. Piyathilake C.J., Hine R.J., Dasanayake A.P., et al. Effect of smoking on folate levels in buccal mucosal cells. Int J Cancer 1992, 52:566-569.
60. Piyathilake C.J., Macaluso M., Hine R.J., Richards E.W., Krumdieck C.L. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994, 60:559-566.
61. Mansoor M.A., Kristensen O., Hervig T., et al. Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and nonsmokers. Clin Chem 1997, 43:2192-2194.
62. McDonald S.D., Perkins S.L., Jodouin C.A., Walker M.C. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am J Obstet Gynecol 2002, 187:620-625.
63. Kim S.H., Kim J.S., Shin H.S., Keen C.L. Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 2003, 19:240-243.
64. Tungtrongchitr R., Pongpaew P., Soonthornruengyot M., et al. Relationship of tobacco smoking with serum vitamin B12, folic acid and haematological indices in healthy adults. Public Health Nutr 2003, 6:675-681.
65. Gabriel H.E., Crott J.W., Ghandour H., et al. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 2006, 83:835-841.
66. Vardavas C.I., Linardakis M.K., Hatzis C.M., Malliaraki N., Saris W.H., Kafatos A.G. Smoking status in relation to serum folate and dietary vitamin intake. Tob Induc Dis 2008, 4:8.
67. Dastur D.K., Quadros E.V., Wadia N.H., Desai M.M., Bharucha E.P. Effect of vegetarianism and smoking on vitamin B12, thiocyanate, and folate levels in the blood of normal subjects. BMJ 1972, 3:260-263.
68. Ortega R.M., López-Sobaler A.M., Martínez R.M., Andrés P., Quintas M.E. Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J Am Coll Nutr 1994, 13:68-72.
69. Sobczak A.J. The effects of tobacco smoke on the homocysteine level-a risk factor of atherosclerosis. Addict Biol 2003, 8:147-158.
70. Margetts B.M., Jackson A.A. The determinants of plasma ß-carotene: interaction between smoking and other lifestyle factors. Eur J Clin Nutr 1996, 50:236-238.
71. Zondervan K.T., Ocke M.C., Smit H.A., Seidell J.C. Do dietary and supplementary intakes of antioxidants differ with smoking status?. Int J Epidemiol 1996, 25:70-79.
72. Wei W., Kim Y., Boudreau N. Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am J Public Health 2001, 91:258-264.
73. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002, 180:121-137.
74. Pagán K., Hou J., Goldenberg R.L., Cliver S.P., Tamura T. Effect of smoking on serum concentrations of total homocysteine and B vitamins in mid-pregnancy. Clin Chim Acta 2001, 306:103-109.
75. Voutilainen S., Rissanen T.H., Virtanen J., Lakka T.A., Salonen J.T. Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001, 103:2674-2680.
76. Padrão P., Lunet N., Santos A.C., Barros H. Smoking, alcohol, and dietary choices: evidence from the Portuguese National Health Survey. BMC Public Health 2007, 7:138.
77. Ortega R.M., Requejo A.M., López-Sobaler A.M., et al. Smoking and passive smoking as conditioners of folate status in young women. J Am Coll Nutr 2004, 23:365-371.
78. Suarez L., Felkner M., Brender J.D., Canfield M., Hendricks K. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J 2008, 12:394-401.
79. Clark J.D., Wilkinson J.D., LeBlanc W.G., et al. Inflammatory markers and secondhand tobacco smoke exposure among U.S. workers. Am J Ind Med 2008, 51:626-632.
80. Baren R.E., Parrish M.E., Shafer K.H., et al. Quad quantum cascade laser spectrometer with dual gas cells for the simultaneous analysis of mainstream and sidestream cigarette smoke. Spectrochim Acta A Mol Biomol Spectrosc 2004, 60:3437-3447.
81. Frasca V., Riazzi B.S., Matthews R.G. In vitro inactivation of methionine synthase by nitrous oxide. J Biol Chem 1986, 261:15823-15826.
82. Kondo H., Osborne M.L., Kolhouse J.F., et al. Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats. J Clin Invest 1981, 67:1270-1283.
83. Northrop-Clewes C.A., Thurnham D.I. Monitoring micronutrients in cigarette smokers. Clin Chim Acta 2000, 377:14-38.
84. Panayiotidis M.I., Stabler S.P., Allen R.H., Ahmad A., White C.W. Cigarette smoke extract increases S-adenosylmethionine and cystathionine in human lung epithelial-like (A549) cells. Chem Biol Interact 2004, 147:87-97.
85. Dekou V., Gudnason V., Hawe E., Miller G.J., Stansbie D., Humphries S.E. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemos 2001, 85:67-74.
86. Saw S.M., Yuan J.M., Ong C.N., et al. Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr 2001, 73:232-239.
87. Osganian S.K., Stampfer M.J., Spigelman D., et al. Distribution of factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA 1999, 281:1189-1196.
88. Mosharov E., Cranford M.R., Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000, 39:13005-13011.
89. Mudd S.H., Poole J.R. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975, 24:721-735.
90. Marangon K., Herbeth B., Lecomte E., Paul-Dauphin A., Grolier P., Chancerelle Y., Artur Y., Siest G. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 1998, 67:231-239.
91. McCarty M.F. Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypotheses 2000, 55:289-293.